Showing results (51-60 of 100) with videos related to

Sort By:
Pageof 10
British Journal of Clinical Pharmacology|July 1, 1992
Impairment of carbamazepine-10, 11-epoxide elimination by valnoctamide, a valpromide isomer, in healthy subjectsF Pisani, A Fazio, C Artesi, et al.
Physical Review. E|July 16, 2017
Classical counterparts of quantum attractors in generic dissipative systemsGabriel G Carlo, Leonardo Ermann, Alejandro M F Rivas, et al.
Psychopharmacology|January 20, 2000
Cytochrome P450 2D6 genotype and steady state plasma levels of risperidone and 9-hydroxyrisperidoneM G Scordo, E Spina, G Facciolà, et al.
Acta Dermato-Venereologica|October 1, 1993
An endocrinological study of patients with primary cutis verticis gyrataR Palazzo, C Schepis, M Ruggeri, et al.
Acta Dermato-Venereologica|January 1, 1990
Prevalence of primary cutis verticis gyrata in a psychiatric population: association with chromosomal fragile sitesC Schepis, R Palazzo, S P Cannavo, et al.
European Journal of Clinical Pharmacology|January 1, 1997
Relationship between plasma desipramine levels, CYP2D6 phenotype and clinical response to desipramine: a prospective studyE Spina, C Gitto, A Avenoso, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 19, 2001
Different enantioselective 9-hydroxylation of risperidone by the two human CYP2D6 and CYP3A4 enzymesN Yasui-Furukori, M Hidestrand, E Spina, et al.
Schizophrenia Research|March 27, 2007
The effect of lamotrigine augmentation of clozapine in a sample of treatment-resistant schizophrenic patients: a double-blind, placebo-controlled studyR Zoccali, M R Muscatello, A Bruno, et al.
Pharmacopsychiatry|April 26, 2014
Can valproic acid be an inducer of clozapine metabolism?F J Diaz, C B Eap, N Ansermot, et al.
Therapeutic Drug Monitoring|September 1, 1990
No effect of thioridazine on plasma concentrations of carbamazepine and its active metabolite carbamazepine-10,11-epoxideE Spina, A M Amendola D'Agostino, M P Ioculano, et al.
Pageof 10